Diseases / Amyotrophic Lateral Sclerosis
Amyotrophic Lateral Sclerosis
Disease- Registered trials
- 779
- Ongoing
- 208/ 27%
- Completed
- 373
Clinical trial landscape
779 registered studies reference this disease. The split below shows how many are ongoing versus completed per phase.
| Phase | Total | Ongoing | Completed | Split |
|---|---|---|---|---|
| Unknown | 232 | 86 | 92 | |
| Not applicable | 183 | 54 | 84 | |
| Phase 2 | 134 | 15 | 84 | |
| Phase 1 | 84 | 18 | 41 | |
| Phase 1/2 | 60 | 18 | 27 | |
| Phase 3 | 42 | 5 | 20 | |
| Phase 2/3 | 27 | 6 | 17 | |
| Early Phase 1 | 12 | 5 | 6 | |
| Phase 4 | 5 | 1 | 2 | |
| All phases | 779 | 208 | 373 |
Ongoing Completed Balance withdrawn, terminated, or status unreported.
Study records: ClinicalTrials.gov →
Recent developments
| Neuroscience Biotech Roundup: BCI Partnership, Licensing Deal, Drive Cohorts | massdevice.com ↗ | |
| New Brain Models, Sensors, and Imaging Tools Speed Drug Development | news-medical.net ↗ | |
| Prothena to Report Second Quarter 2026 Financial Results on August 6 | firstwordpharma.com ↗ | |
| Brain Organoid Advances: Live-Cell Monitoring and Space-Accelerated Aging | med.stanford.edu ↗ | |
| Actor Eric Dane Dies of ALS at 53; NFL Star Chris Johnson Also Diagnosed | medpagetoday.com ↗ | |
| HMNC, Cartesian, Waiv, Brainstorm Announce New Biotech Financings | precisionmedicineonline.com ↗ | |
| NeuroSense Reports 65% Survival Benefit for ALS Drug PrimeC, Secures South Korean Patent | nature.com ↗ | |
| Experimental ALS Therapies QRL-201 and Neflamapimod Advance in Clinical Trials | medicalxpress.com ↗ | |
| FDA grants Fast Track designation to Coya Therapeutics' COYA 302 for ALS | theglobeandmail.com ↗ | |
| UC San Diego Space Research Aims to Protect Lives on Earth | today.ucsd.edu ↗ |
Headlines link to the original publisher. Sources limited to a reviewed list of journals, regulators, and medical press.